The authors reply to the Hematology/Oncology Pharmacy Association's (HOPA) alternative viewpoint on the 2016 American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit. They reiterate the need of pharmacy graduates to possess a foundation of oncology knowledge and they reject the oncology-related topics recommended by the HOPA task force for addition to the ACCP tier classification system of oncologic disorders.